Sorrento Therapeutics, Inc.

Simbol: SRNE

NASDAQ

0.014

USD

Tržna cena danes

  • -0.0174

    Razmerje P/E

  • -0.0016

    Razmerje PEG

  • 7.72M

    Kapaciteta MRK

  • 0.00%

    Donos DIV

Sorrento Therapeutics, Inc. (SRNE) Finančni izkazi

Na grafu so prikazane privzete številke v dinamiki za Sorrento Therapeutics, Inc. (SRNE). Prihodki podjetja prikazujejo povprečje NaN M, ki je NaN % gowth. Povprečni bruto dobiček za celotno obdobje je NaN M, ki je NaN %. Povprečno razmerje bruto dobička je NaN %. Rast čistega dobička za lanskoletno poslovanje podjetja je NaN %, kar je enako NaN % % v povprečju v celotni zgodovini podjetja.,

Bilanca stanja

Če pogledamo fiskalno pot podjetja Sorrento Therapeutics, Inc., opazimo povprečno rast sredstev. Zanimivo je, da ta stopnja znaša , kar odraža tako visoke kot tudi padce podjetja. Pri primerjavi četrtletja s četrtletjem se ta številka prilagodi na . Pogled nazaj v preteklo leto razkrije skupno spremembo sredstev v višini NaN. Vrednost za delničarje, kot jo prikazuje celotni lastniški kapital, je ovrednotena z vrednostjo NaN v valuti poročanja. Letna sprememba tega vidika je NaN%.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003

balance-sheet.row.cash-and-short-term-investments

050126.956.5
22.5
159
20.9
83.5
136.4
71.9
31.7
5.1
3.5
5.3
3.4
0.4
0
0
0
0
0

balance-sheet.row.short-term-investments

026.390.20
0
0.3
0.4
1.1
97.4
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

024.518.715.5
14.5
4.4
3.9
3
2.6
0.7
0.4
0.1
0.1
0.2
0
0
0
0
0
0
0

balance-sheet.row.inventory

0108.11.8
3.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-current-assets

03.17.53.7
27.2
16.2
4.9
3.2
2
1.3
0.6
0.1
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-current-assets

096.417386.2
67.6
179.6
29.7
89.7
141
73.9
32.6
5.3
3.6
5.6
3.5
0.4
0
0
0
0
0

balance-sheet.row.property-plant-equipment-net

0138.4126.573.9
76.3
24.4
19.3
12.7
7.2
2.3
2.4
1.5
1
0.1
0.1
0
0
0
0
0
0

balance-sheet.row.goodwill

080.379.543.6
38.3
38.3
38.3
41.5
20.6
24
24
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0136.9259.773.7
63.3
66.3
71
64.8
3.9
31
33.3
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

0217.2339.2117.2
101.6
104.6
109.3
106.3
24.5
55
57.4
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-investments

017.251.3256.4
262.2
265
270
189
170.1
10
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

03.74.82
49.9
50.6
3.3
3.9
0.6
0.3
0.1
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-non-current-assets

0376.5521.8449.6
490
444.5
401.9
311.9
202.5
67.6
60
1.5
1
0.1
0.1
0
0
0
0
0
0

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0472.8694.8535.8
557.6
624.1
431.6
401.6
343.5
141.5
92.6
6.8
4.6
5.7
3.6
0.4
0
0
0
0
0

balance-sheet.row.account-payables

047.527.424.7
27.6
13.8
9.9
8.3
1.3
1.7
2.2
0.4
0.2
0.2
0.3
0
0
0.5
0
0.1
0.1

balance-sheet.row.short-term-debt

030.243.526.8
39.6
10.2
0
0.2
4.8
3.3
0.4
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

0104.3194.1142.6
251.2
223.1
5.2
47.1
4.4
8.8
4.4
0
0
0
0
0
0
0
0
0
0

Deferred Revenue Non Current

07.1118.9113.2
114.4
116.3
119.3
134.4
110.9
1.1
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0249.667.440.5
44.4
35
65.2
57.9
-86.2
3.5
3
0.1
0.1
0.2
0
0
0
0
0
0.2
0.2

balance-sheet.row.total-non-current-liabilities

0166.6477.2298.6
409.7
355
146
239
171.7
23.3
20.3
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

099.19553.9
55.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0494.5616.7395.1
524.9
416.6
225
315.1
202.6
32.8
25.8
0.6
0.4
0.6
0.4
0
0
0.5
0
0.3
0.3

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

00.100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

0-1959.4-1386.6-958.3
-659.8
-367.8
-165.1
-174.3
-113.3
-67.5
-32.9
-11
-6.1
-2.9
-1.1
-1.7
-1.5
-1.2
-0.8
-1.1
-1.1

balance-sheet.row.accumulated-other-comprehensive-income-loss

01.510.5
-0.3
0
0.2
-0.1
73.6
-1.7
-0.9
-0.5
-0.2
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

01939.31464.31122.9
738.7
577.2
364.4
254.4
184.9
177.9
100.6
17.6
10.5
7.9
4.2
2.1
1.5
0.7
0.7
0.7
0.7

balance-sheet.row.total-stockholders-equity

0-18.678.7165.2
78.6
209.5
199.6
80
145.2
108.7
66.8
6.2
4.2
5.1
3.2
0.4
0
-0.5
0
-0.3
-0.3

balance-sheet.row.total-liabilities-and-stockholders-equity

0472.8694.8535.8
557.6
624.1
424.6
401.6
343.5
141.5
92.6
6.8
4.6
5.7
3.6
0.4
0
0
0
0
0

balance-sheet.row.minority-interest

0-3.1-0.6-24.4
-45.8
-2
0
6.5
-4.2
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

0-21.778.1140.7
32.8
207.5
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

043.5141.5256.4
262.2
265.3
270.4
190.1
267.5
10
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

0134.5237.6169.4
290.8
233.3
5.2
47.3
9.2
12.1
4.8
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-debt

0110.9200.9112.9
268.3
74.5
-15.2
-35.1
-29.8
-59.8
-26.9
-5.1
-3.5
-5.3
-3.4
-0.4
0
0
0
0
0

Izkaz denarnih tokov

V zadnjem obdobju se je v finančnem okolju Sorrento Therapeutics, Inc. opazno spremenil prosti denarni tok, ki se je spremenil v NaN. Podjetje je nedavno povečalo svoj osnovni kapital z izdajo NaN, kar kaže na razliko NaN v primerjavi s prejšnjim letom. Družba je pri naložbenju porabila neto denarna sredstva v višini NaN v valuti poročanja. To je premik za NaN v primerjavi s prejšnjim letom. V istem obdobju je družba zabeležila NaN, NaN in NaN, ki so pomembne za razumevanje naložbenih in odplačilnih strategij podjetja. Družba je pri financiranju porabila NaN, pri čemer je razlika v primerjavi z letom prej znašala NaN. Poleg tega je podjetje namenilo NaN za izplačilo dividend svojim delničarjem. Hkrati je izvajalo tudi druge finančne manevre, imenovane NaN, ki so prav tako pomembno vplivali na denarni tok v tem obdobju. Te sestavine skupaj tvorijo celovito sliko finančnega stanja podjetja in strateškega pristopa k upravljanju denarnih tokov.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003

cash-flows.row.net-income

0-577.8-429.1-314.4
-363
-212.5
11.1
-63.9
-50.1
-34.7
-21.9
-4.8
-3.2
-1.8
-0.9
-0.2
-0.3
-0.4
0.3
0
0

cash-flows.row.depreciation-and-amortization

013.212.511
11
9.1
7.1
2.9
2.4
3.2
1.3
0.3
0.2
0
0
0
0
0
0
0
0

cash-flows.row.deferred-income-tax

0-1.8-35.9-2.1
-0.4
-6.1
-35.7
1
33.3
-1.7
0
0
3.2
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

074.890.231.4
12.6
6.2
5
4.7
7
3.9
1.8
0.9
0.3
0.3
0.1
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

069.6-2.83.8
7.2
6
-17.6
25.5
14.8
-0.2
0.4
-0.1
0
0
0.2
0
-0.5
0.4
-0.3
0
0

cash-flows.row.account-receivables

0-5.7-3-1.1
0
0
0
0
-0.2
0
0.1
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-9.58.610.2
0
0
0
0
7.8
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.account-payables

09.9-3.9-3.7
10.2
3.6
1.6
3.7
-2.7
-0.5
0.9
0
0
-0.1
0.1
0
-0.5
0
0
0
0

cash-flows.row.other-working-capital

074.9-4.6-1.7
-3
2.4
-19.2
21.8
9.9
0.3
-0.6
-0.1
0
0.1
0
0
0
0
-0.3
0
0

cash-flows.row.other-non-cash-items

0128.183.4110.8
159.5
85.6
-69
-41.1
-49.5
0.7
1.9
0
-3.2
0
0
0
0.1
0
0
0
0

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-13.7-8.9-37.6
-11.4
-11.2
-11
-6.9
-3.7
-0.6
-0.9
-0.5
-1.1
0
0
0
0
0
0
0
0

cash-flows.row.acquisitions-net

0-14.9-36-2.3
-9.7
0
-5.6
-10.6
27.8
0
0.4
0
0
0
0.1
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0000
0
0
0
0
-11.5
-10
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

00124.80
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

0000
-17
-10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-cash-used-for-investing-activites

0-28.579.8-39.9
-38.2
-21.2
-16.5
-17.5
12.6
-10.6
-0.5
-0.5
-1.1
0
0.1
0
0
0
0
0
0

cash-flows.row.debt-repayment

0-188.3-85.7-205.6
-3.1
-45.7
-53.2
-9.5
-3.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

0402.3201.8317.9
47.7
83.6
57.9
108
0
71.8
37.7
5.9
2
3.4
4.1
0.6
0.7
0
0
0
0

cash-flows.row.common-stock-repurchased

000-55
0
0
0
-15.6
0
0
37701.4
5.9
0
4.2
6
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

097.765.2116.9
34.3
288.1
48.9
48.8
-0.3
7.8
-37695.5
-5.9
0
-4.2
-6
0
0
0
0
0
0

cash-flows.row.net-cash-used-provided-by-financing-activities

0311.7181.3174.2
78.9
326
53.7
131.7
-3.3
79.6
43.6
6
2
3.4
4.1
0.6
0.7
0
0
0
0

cash-flows.row.effect-of-forex-changes-on-cash

0-2.40.80.9
-0.3
-0.1
0.1
0
0
0
0
0
0
0
0.7
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0-13-19.8-24.3
-132.6
192.9
-62
43.4
-32.9
40.2
26.6
1.6
-1.8
1.8
4.1
0.4
0
0
0
0
0

cash-flows.row.cash-at-end-of-period

023.636.756.5
80.8
213.3
20.4
82.4
39
71.9
31.7
5.1
3.5
5.3
3.4
0.4
0
0
0
0
0

cash-flows.row.cash-at-beginning-of-period

036.756.580.8
213.3
20.4
82.4
39
71.9
31.7
5.1
3.5
5.3
3.4
-0.7
0
0
0
0
0
0

cash-flows.row.operating-cash-flow

0-293.9-281.8-159.5
-173
-111.8
-99.2
-70.9
-42.1
-28.8
-16.5
-3.8
-2.7
-1.5
-0.7
-0.2
-0.7
0
0
0
0

cash-flows.row.capital-expenditure

0-13.7-8.9-37.6
-11.4
-11.2
-11
-6.9
-3.7
-0.6
-0.9
-0.5
-1.1
0
0
0
0
0
0
0
0

cash-flows.row.free-cash-flow

0-307.5-290.7-197.1
-184.4
-123
-110.2
-77.8
-45.8
-29.4
-17.4
-4.3
-3.8
-1.6
-0.8
-0.2
-0.7
0
0
0
0

Vrstica izkaza poslovnega izida

Prihodki Sorrento Therapeutics, Inc. so se v primerjavi s prejšnjim obdobjem spremenili za NaN%. Bruto dobiček podjetja SRNE znaša NaN. Odhodki iz poslovanja podjetja so NaN in so se v primerjavi s prejšnjim letom spremenili za NaN%. Odhodki za amortizacijo znašajo NaN, kar je NaN% sprememba glede na zadnje obračunsko obdobje. Stroški poslovanja so sporočeni v višini NaN, ki kaže NaN% spremembo glede na preteklo leto. Stroški prodaje in trženja znašajo NaN, kar pomeni NaN% spremembo v primerjavi s preteklim letom. EBITDA na podlagi zadnjih podatkov znaša NaN in predstavlja NaN% rast v primerjavi s preteklim letom. Prihodki iz poslovanja so NaN, ki kažejo NaN% spremembo v primerjavi s preteklim letom. Sprememba čistih prihodkov je NaN%. Čisti prihodki v zadnjem letu so znašali NaN.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003

income-statement-row.row.total-revenue

062.852.940
31.4
21.2
151.9
8.2
4.6
3.8
0.5
0.6
0.5
0.7
0
0
0
0
0
0
0

income-statement-row.row.cost-of-revenue

033.5139.9
12.2
7.1
3.9
0.8
1.9
2
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.gross-profit

029.439.930
19.2
14.1
147.9
7.3
2.6
1.8
0.5
0.6
0.5
0.7
0
0
0
0
0
0
0

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

04.34.14.1
3.9
3
2.6
0.8
1.2
2.3
0.8
0
0
0
0
0
0
0
-0.3
0
0

income-statement-row.row.operating-expenses

0407.9407.9231.6
214.4
143.6
96.5
67.2
52.6
36.3
16.1
5.4
3.8
2.5
1
0.2
0.2
0.4
-0.3
0
0

income-statement-row.row.cost-and-expenses

0441.3420.9241.5
226.6
150.7
100.4
68
54.6
38.4
16.1
5.4
3.8
2.5
1
0.2
0.2
0.4
-0.3
0
0

income-statement-row.row.interest-income

0000
1.1
0.9
0.2
0.3
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

08.610.220.2
36.1
57.6
5
1.6
1.7
1.6
0.3
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-183.2-94.5-109.1
-164.4
-63.4
-10
31.9
60.2
-1.6
-0.2
0
0
0
0
0
0
0
-0.3
0
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

04.34.14.1
3.9
3
2.6
0.8
1.2
2.3
0.8
0
0
0
0
0
0
0
-0.3
0
0

income-statement-row.row.total-operating-expenses

0-183.2-94.5-109.1
-164.4
-63.4
-10
31.9
60.2
-1.6
-0.2
0
0
0
0
0
0
0
-0.3
0
0

income-statement-row.row.interest-expense

08.610.220.2
36.1
57.6
5
1.6
1.7
1.6
0.3
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

014-15.49.7
12.1
9.1
7.1
2.9
2.4
3.2
1.3
0.3
0.2
0
0
0
0
0
0
0
0

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0-378.5-368-201.5
-195.2
-150.4
25.3
-96.8
-74
-34.7
-21.7
-4.9
-3.2
-1.8
-1
-0.2
-0.2
-0.4
-0.3
0
0

income-statement-row.row.income-before-tax

0-561.7-462.5-310.6
-359.6
-213.8
15.3
-64.8
-13.8
-36.4
-21.9
-4.8
-3.2
-1.8
-0.9
0
-0.3
0
-0.6
0
0

income-statement-row.row.income-tax-expense

0-2.4-33.5-2
-0.5
-6.3
-36
-0.9
36.3
-1.7
0
0
0
0
0
0
0
0.4
-0.3
0
0

income-statement-row.row.net-income

0-559.3-429-308.6
-359.1
-203.5
9.1
-60.9
-45.8
-34.7
-21.9
-4.8
-3.2
-1.8
-0.9
-0.2
-0.3
-0.4
-0.3
0
0

Pogosto zastavljeno vprašanje

Kaj je Sorrento Therapeutics, Inc. (SRNE) skupna sredstva?

Sorrento Therapeutics, Inc. (SRNE) skupna sredstva so 472840000.000.

Kakšen je letni prihodek podjetja?

Letni prihodki so N/A.

Kolikšna je stopnja dobička podjetja?

Dobiček podjetja je 0.416.

Kakšen je prosti denarni tok podjetja?

Prosti denarni tok je -0.323.

Kolikšna je neto stopnja dobička podjetja?

Čista stopnja dobička je -9.463.

Kolikšni so skupni prihodki podjetja?

Celotni prihodki so -5.619.

Kaj je Sorrento Therapeutics, Inc. (SRNE) čisti dobiček (čisti dobiček)?

Čisti dobiček (čisti prihodek) je -559331000.000.

Kolikšen je skupni dolg podjetja?

Skupni dolg je 134504000.000.

Kolikšni so stroški poslovanja?

Stroški poslovanja so 407888000.000.

Kolikšno je število denarnih sredstev podjetja?

Denarna sredstva podjetja so 0.000.